van den Berg C W, Harrison R A, Morgan B P
Dept. of Medical Biochemistry, University of Wales College of Medicine, Cardiff, U.K.
Immunology. 1993 Mar;78(3):349-57.
An inhibitor of the membrane attack complex of complement was isolated from the membranes of sheep erythrocytes. Fast protein liquid chromatography (FPLC) and affinity purification procedures for this sheep complement-inhibiting protein (SCIP) both yielded a pure protein with an apparent M(r) of 19,000 under reducing and non-reducing conditions. Incubation of the denatured protein with neuraminidase and Endo-F reduced the apparent M(r) to 18,000 and 15,000 respectively, while treatment with O-deglycosidase or phosphatidylinositol-specific phospholipase C (PIPLC) did not affect the apparent M(r). SCIP was detectable on erythrocytes and lymphocytes but not on platelets and could partially be removed by PIPLC treatment. Deglycosylation of the pure protein markedly reduced and PIPLC treatment abolished its activity. A monoclonal antibody (mAb) raised against sheep complement-inhibiting protein (SCIP) enhanced the susceptibility of sheep erythrocytes to lysis by homologous complement. SCIP inhibited complement after the stage of C5b-7 formation. Amino-terminal protein sequence was obtained and was shown to be similar to that of human CD59. All these features suggest that SCIP is the sheep equivalent of human CD59. Human CD59 has been reported to be species selective in that it inhibits complement from relatively few species. However, SCIP efficiently inhibited lysis of guinea-pig erythrocytes by complement from a wide range of species tested indicating that it is a potent and non-selective inhibitor of the membrane attack complex of complement (MAC).
从绵羊红细胞膜中分离出一种补体膜攻击复合物抑制剂。针对这种绵羊补体抑制蛋白(SCIP)的快速蛋白质液相色谱(FPLC)和亲和纯化程序,在还原和非还原条件下均产生了一种表观分子量为19,000的纯蛋白。将变性蛋白与神经氨酸酶和内切糖苷酶F孵育后,表观分子量分别降至18,000和15,000,而用O-糖苷酶或磷脂酰肌醇特异性磷脂酶C(PIPLC)处理则不影响表观分子量。在红细胞和淋巴细胞上可检测到SCIP,但在血小板上未检测到,并且PIPLC处理可部分去除SCIP。纯蛋白的去糖基化显著降低其活性,而PIPLC处理则使其活性丧失。针对绵羊补体抑制蛋白(SCIP)产生的单克隆抗体(mAb)增强了绵羊红细胞对同源补体裂解的敏感性。SCIP在C5b-7形成阶段之后抑制补体。获得了氨基末端蛋白质序列,显示其与人CD59的序列相似。所有这些特征表明SCIP是人类CD59的绵羊等同物。据报道,人类CD59具有物种选择性,即它仅抑制少数物种的补体。然而,SCIP有效抑制了来自广泛测试物种的补体对豚鼠红细胞的裂解,表明它是补体膜攻击复合物(MAC)的一种强效且非选择性的抑制剂。